Top Markets
Coin of the day
Lumos Diagnostics Holdings Limited Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited

LDX
Pozycja w akcjach #23727
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes... Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Cena akcji
$0.0740549
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$69.97M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
21.33%
Kraj
AU
Handel Lumos Diagnostics Holdings Limited (LDX)

Kategoria

Historia stopy dywidendy dla Lumos Diagnostics Holdings Limited (LDX)
Stopa dywidendy (TTM) dla Lumos Diagnostics Holdings Limited (symbol akcji: LDX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Lumos Diagnostics Holdings Limited (LDX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji